Bendit 100 mg Inj

Bendamustine Hydrochloride belongs to a class of chemotherapy medications that combines properties of alkylating agents, working by attaching to and damaging the DNA within cancer cells, which prevents them from properly replicating and dividing. This disruption ultimately leads to the destruction of rapidly dividing cancer cells, helping slow disease progression. It is commonly used in the treatment of chronic lymphocytic leukemia (CLL), a slow-growing blood cancer affecting white blood cells, often as part of a broader treatment approach. Bendamustine is also used to treat certain types of non-Hodgkin's lymphoma, particularly indolent forms that have progressed after previous treatment, offering an important option for ongoing disease management. The medication is administered through intravenous infusion, typically in a hospital or specialized oncology setting, allowing healthcare providers to closely monitor the patient during and after administration. Treatment schedules and dosing are carefully individualized based on the specific type and stage of cancer, as well as the patient's overall health and treatment history. Regular monitoring, including blood counts, is an important part of care throughout treatment to help guide safe and effective dosing. Many patients experience meaningful disease control and improved outcomes as part of a comprehensive treatment plan involving Bendamustine. As with all chemotherapy medications, Bendamustine Hydrochloride injection should be administered under the close supervision of an experienced oncology healthcare team.